The ultimate goal of the research proposed here is to define the molecular mechanism underlying thi control of telomere length in human cells. Telomere length control is of particular interest within the context of human cancer since the activation of a telomere maintenance system is a key step in tumorigenesis. In the preceding funding period we established TRF1 as a key regulator of telomere length in humai cells. We also identified the TRF1 -interacting factor tankyrase and showed that this telomeric PARP function as an upstream negative regulator of TRF1. Our preliminary evidence suggests a role for the third componer of the TAFt complex, TIN2, in regulating the TAF1-tankyrase interplay. Here we propose three sets c experiments (AlMs 1-3) to further dissect the way the TRF1/tankyrase/TIN2 network modulates telomer maintenance by telomerase. Additional components of the TRF1 complex will be sought in AIM 4 and their rol in telomere length homeostasis will be addressed using the tools we have developed in the preceding fundin! period. We also showed that the TRF1 paralog, TRF2, contributes to telomere length control and identified TRF2-interacting protein that is the ortholog of the main telomere length regulator in budding yeast. Th discovery of this protein, hRapl, and its remarkable divergence from budding yeast Rapi p raises the question of the role of both TRF2 and hRap 1 in telomere length control, an issue that will be addressed in AIM 5. The experiments proposed in this renewal application are based on the assumption that the cis-acting mechanism of telomere length control in human cells will be primarily mediated by the two main duple telomeric DNA binding proteins, TRF1 and TRF2. Our rationale is that by focusing on the complexes formed b TRF1 and TRF2, we should be able to gain insight into the key features of the telomere length control circuil Given the role of telomere dynamics in human cancer, understanding the regulation of human telomer maintenance is of central importance.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Research Project (R01)
Project #
Application #
Study Section
Cell Development and Function Integrated Review Group (CDF)
Program Officer
Okano, Paul
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Rockefeller University
Anatomy/Cell Biology
Other Domestic Higher Education
New York
United States
Zip Code
Lovejoy, Courtney A; Li, Wendi; Reisenweber, Steven et al. (2012) Loss of ATRX, genome instability, and an altered DNA damage response are hallmarks of the alternative lengthening of telomeres pathway. PLoS Genet 8:e1002772
Sfeir, Agnel; de Lange, Titia (2012) Removal of shelterin reveals the telomere end-protection problem. Science 336:593-7
Wu, Peng; Takai, Hiroyuki; de Lange, Titia (2012) Telomeric 3' overhangs derive from resection by Exo1 and Apollo and fill-in by POT1b-associated CST. Cell 150:39-52
Davoli, Teresa; de Lange, Titia (2011) The causes and consequences of polyploidy in normal development and cancer. Annu Rev Cell Dev Biol 27:585-610
Wu, Peng; van Overbeek, Megan; Rooney, Sean et al. (2010) Apollo contributes to G overhang maintenance and protects leading-end telomeres. Mol Cell 39:606-17
de Lange, T (2010) How shelterin solves the telomere end-protection problem. Cold Spring Harb Symp Quant Biol 75:167-77
Takai, Kaori K; Hooper, Sarah; Blackwood, Stephanie et al. (2010) In vivo stoichiometry of shelterin components. J Biol Chem 285:1457-67
Kabir, Shaheen; Sfeir, Agnel; de Lange, Titia (2010) Taking apart Rap1: an adaptor protein with telomeric and non-telomeric functions. Cell Cycle 9:4061-7
Sfeir, Agnel; Kosiyatrakul, Settapong T; Hockemeyer, Dirk et al. (2009) Mammalian telomeres resemble fragile sites and require TRF1 for efficient replication. Cell 138:90-103
de Lange, Titia (2009) How telomeres solve the end-protection problem. Science 326:948-52

Showing the most recent 10 out of 32 publications